SSc-related bone involvement is characterized by an impairment in bone quality in addition to reduced bone quantity, and TBS can identify the negative effect of GC on bone microarchitecture. PubMed, J Rheumatol, 12/01/2014. (Also see: Osteoporosis and Scleroderma and Osteoporosis and Glucocorticoids, Steroids (Prednisone)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.